Inventiva says last patient visit in lanifibranor Nativ3 Phase 3
Inventiva SA said the last patient visit has been completed in its Nativ3 Phase 3 clinical trial of lanifibranor in MASH.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.